全球寡核苷酸合成市场规模、份额、趋势和成长分析报告（2026-2034年）

寡核苷酸合成市场预计将从 2025 年的 47.2 亿美元成长到 2034 年的 148.1 亿美元，2026 年至 2034 年的复合年增长率为 13.54%。

受分子生物学和遗传学研究活性化的推动，全球寡核苷酸合成市场经历了强劲增长。寡核苷酸是合成的短链核苷酸，用于遗传学研究、诊断和治疗方法开发。这些分子在基因序列测定、聚合酵素链锁反应(PCR) 技术和标靶药物开发等应用中发挥着至关重要的作用。

寡核苷酸合成市场的主要驱动力包括生物技术和药物研发的扩张。基因治疗和个人化医疗领域投资的增加正在加速对高品质合成寡核苷酸的需求。研究机构和製药公司依赖这些分子进行基因表现研究和创新治疗方法的开发。

随着基因组学和生物技术的不断进步，寡核苷酸合成市场预计将持续成长。合成技术的改进和自动化将提高生产效率和精确度。随着遗传学和分子医学领域科学研究的拓展，合成寡核苷酸的需求预计将保持强劲。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球寡核苷酸合成市场：依产品划分

• 市场分析、洞察与预测
• 寡核苷酸
• 设备/合成设备
• 试剂
• 服务

第五章 全球寡核苷酸合成市场：依应用领域划分

• 市场分析、洞察与预测
• PCR引子
• PCR检测与试剂盒
• 定序
• DNA微阵列
• 萤光原位杂合反应（FISH）
• 反义寡核苷酸
• 其他用途

第六章：全球寡核苷酸合成市场：依最终用途划分

• 市场分析、洞察与预测
• 学术研究机构
• 诊断检查室
• 製药和生物技术公司

第七章 全球寡核苷酸合成市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第八章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第九章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • Danaher
  • Revvity Discovery Limited
  • Agilent Technologies Inc
  • Bio-Synthesis Inc
  • Kaneka Eurogentec SA
  • LGC Biosearch Technologies
  • Biolegio
  • Twist Bioscience

The Oligonucleotide Synthesis Market size is expected to reach USD 14.81 Billion in 2034 from USD 4.72 Billion (2025) growing at a CAGR of 13.54% during 2026-2034.

The global oligonucleotide synthesis market has experienced strong growth due to increasing research in molecular biology and genetic studies. Oligonucleotides are short sequences of nucleotides that are synthesized for use in genetic research, diagnostics, and therapeutic development. These molecules play a crucial role in applications such as gene sequencing, polymerase chain reaction techniques, and targeted drug development.

Key drivers of the oligonucleotide synthesis market include the expansion of biotechnology and pharmaceutical research. Increasing investment in genetic therapies and personalized medicine has accelerated demand for high-quality synthetic oligonucleotides. Research institutions and pharmaceutical companies rely on these molecules for studying gene expression and developing innovative treatments.

Looking ahead, the oligonucleotide synthesis market is expected to grow as advances in genomics and biotechnology continue. Improvements in synthesis technologies and automation will enhance production efficiency and accuracy. As scientific research in genetics and molecular medicine expands, the demand for synthetic oligonucleotides will remain strong.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Oligonucleotides
• Equipment/Synthesizer
• Reagents
• Services

By Application

• PCR Primers
• PCR Assays and Panels
• Sequencing
• DNA Microarrays
• Fluorescence In Situ Hybridization (FISH)
• Antisense Oligonucleotides
• Other Applications

By End-use

• Academic Research Institutes
• Diagnostic Laboratories
• Pharmaceutical and Biotechnology Companies

COMPANIES PROFILED

• Thermo Fisher Scientific Inc, Merck KGaA, Danaher, Revvity Discovery Limited, Agilent Technologies Inc, BioSynthesis Inc, Kaneka Eurogentec SA, LGC Biosearch Technologies, Biolegio, Twist Bioscience
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Oligonucleotides Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Equipment/Synthesizer Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. PCR Primers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR Assays and Panels Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. DNA Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Fluorescence In Situ Hybridization (FISH) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Antisense Oligonucleotides Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Academic Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL OLIGONUCLEOTIDE SYNTHESIS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Thermo Fisher Scientific Inc
  • 9.2.2 Merck KGaA
  • 9.2.3 Danaher
  • 9.2.4 Revvity Discovery Limited
  • 9.2.5 Agilent Technologies Inc
  • 9.2.6 Bio-Synthesis Inc
  • 9.2.7 Kaneka Eurogentec S.A
  • 9.2.8 LGC Biosearch Technologies
  • 9.2.9 Biolegio
  • 9.2.10 Twist Bioscience